CCP
GOSS icon

Clough Capital Partners’s Gossamer Bio GOSS Stock Holding History

Clough Capital Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-159,725
Closed -$1.3M – 128
2021
Q2 		$1.3M Sell
159,725
-298,909
-65% -$2.59M 0.07% 102
2021
Q1 		$4.24M Sell
458,634
-1,200
-0.3% -$12.1K 0.19% 83
2020
Q4 		$4.45M Hold
459,834
– – 0.32% 74
2020
Q3 		$5.71M Hold
459,834
– – 0.41% 67
2020
Q2 		$5.98M Hold
459,834
– – 0.59% 69
2020
Q1 		$4.67M Hold
459,834
– – 0.46% 51
2019
Q4 		$7.19M Sell
459,834
-31,900
-6% -$643K 0.61% 59
2019
Q3 		$8.26M Buy
491,734
+41,800
+9% +$831K 0.68% 41
2019
Q2 		$9.91M Sell
449,934
-30,300
-6% -$580K 0.97% 37
2019
Q1 		$10.2M Buy
+480,234
New +$10M 0.89% 37

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Clough Capital Partners's GOSS Position: Q3 2021 in Review

Clough Capital Partners sold out of Gossamer Bio (GOSS) in Q3 2021, closing a stake of 159,725 shares — an estimated $1.3M sold.

Clough Capital Partners first reported a position in GOSS in Q1 2019 and held it in 10 quarters. The position peaked at $10.2M in Q1 2019. 127 funds tracked by Wall St. Rank hold GOSS as of Q3 2021.

  • Clough Capital Partners reported no remaining Gossamer Bio position as of Q3 2021 after selling out during the quarter.
  • Clough Capital Partners sold 159,725 Gossamer Bio shares in Q3 2021, an estimated $1.3M.
  • Clough Capital Partners first reported a position in Gossamer Bio in Q1 2019 and held it in 10 quarters.
  • Clough Capital Partners's Gossamer Bio position peaked at $10.2M in Q1 2019.
  • 127 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2021.

Based on Clough Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.